Intranasal Drug & Vaccine Delivery Market by Product (Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler), Dosage (Multi-Dose, Unit-Dose), Application, Distribution Channel - Global Forecast 2024-2030

Intranasal Drug & Vaccine Delivery Market by Product (Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler), Dosage (Multi-Dose, Unit-Dose), Application, Distribution Channel - Global Forecast 2024-2030


The Intranasal Drug & Vaccine Delivery Market size was estimated at USD 51.89 billion in 2023 and expected to reach USD 55.88 billion in 2024, at a CAGR 8.17% to reach USD 89.93 billion by 2030.

Global Intranasal Drug & Vaccine Delivery Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intranasal Drug & Vaccine Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intranasal Drug & Vaccine Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intranasal Drug & Vaccine Delivery Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AstraZeneca PLC, Bausch Health Companies Inc., Baxter International, Inc., Becton, Dickinson, and Company, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Marina Biotech, Inc., Merck & Co., Inc., Neurelis Inc., Novartis AG, OptiNose, Inc., Pfizer Inc., Teleflex Incorporated, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Intranasal Drug & Vaccine Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Liquid Delivery Device

Powder Delivery Device

Pressurized Metered Dose Inhaler

Dosage
Multi-Dose

Unit-Dose

Application
Neurological Disorders

Pain Management

Respiratory Disorders

Vaccination

Distribution Channel
Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intranasal Drug & Vaccine Delivery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intranasal Drug & Vaccine Delivery Market?
3. What are the technology trends and regulatory frameworks in the Intranasal Drug & Vaccine Delivery Market?
4. What is the market share of the leading vendors in the Intranasal Drug & Vaccine Delivery Market?
5. Which modes and strategic moves are suitable for entering the Intranasal Drug & Vaccine Delivery Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Intranasal Drug & Vaccine Delivery Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of respiratory and neurological diseases
5.1.1.2. Expansion of supply chain networks and commercialization
5.1.1.3. Rise in number of prescriptions for non-invasive drug delivery routes
5.1.2. Restraints
5.1.2.1. Side effects associated with the use of nasal routes
5.1.3. Opportunities
5.1.3.1. Improving healthcare infrastructure and advanced treatment availability in developing economies
5.1.3.2. Technological advancements related to nasal drug delivery systems
5.1.4. Challenges
5.1.4.1. Development challenges such as requirements of large dose of vaccine and administration difficulties through the nasal route
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Intranasal Drug & Vaccine Delivery Market, by Product
6.1. Introduction
6.2. Liquid Delivery Device
6.3. Powder Delivery Device
6.4. Pressurized Metered Dose Inhaler
7. Intranasal Drug & Vaccine Delivery Market, by Dosage
7.1. Introduction
7.2. Multi-Dose
7.3. Unit-Dose
8. Intranasal Drug & Vaccine Delivery Market, by Application
8.1. Introduction
8.2. Neurological Disorders
8.3. Pain Management
8.4. Respiratory Disorders
8.5. Vaccination
9. Intranasal Drug & Vaccine Delivery Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Intranasal Drug & Vaccine Delivery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Intranasal Drug & Vaccine Delivery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.
10. South Korea
11.
11. Taiwan
11.
12. Thailand
11.
13. Vietnam
12. Europe, Middle East & Africa Intranasal Drug & Vaccine Delivery Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.
10. Nigeria
12.
11. Norway
12.
12. Poland
12.
13. Qatar
12.
14. Russia
12.
15. Saudi Arabia
12.
16. South Africa
12.
17. Spain
12.
18. Sweden
12.
19. Switzerland
12.
20. Turkey
12.
21. United Arab Emirates
12.
22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 3M Company
14.1.2. AstraZeneca PLC
14.1.3. Bausch Health Companies Inc.
14.1.4. Baxter International, Inc.
14.1.5. Becton, Dickinson, and Company
14.1.6. GlaxoSmithKline PLC
14.1.7. Johnson & Johnson Services, Inc.
14.1.8. Marina Biotech, Inc.
14.1.9. Merck & Co., Inc.
14.1.
10. Neurelis Inc.
14.1.
11. Novartis AG
14.1.
12. OptiNose, Inc.
14.1.
13. Pfizer Inc.
14.1.
14. Teleflex Incorporated
14.1.
15. Teva Pharmaceutical Industries Ltd.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. INTRANASAL DRUG & VACCINE DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTRANASAL DRUG & VACCINE DELIVERY MARKET DYNAMICS
FIGURE 7. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 10. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. INTRANASAL DRUG & VACCINE DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. INTRANASAL DRUG & VACCINE DELIVERY MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings